Literature DB >> 1324560

Human herpesvirus 6 (HHV-6) infection in the central nervous system.

K Yamanishi1, K Kondo, T Mukai, T Kondo, H Nagafuji, T Kato, T Okuno, T Kurata.   

Abstract

Human herpesvirus 6 (HHV 6) was isolated from patients with exanthema subitum (ES) with a high frequency, and it is now believed that this virus causes ES as a primary infection in childhood. HHV 6 infection is highly prevalent in early childhood and this virus may infect infants through the saliva mainly from mother to child. HHV 6 has a tropism to CD4+ cells and destroys cells in vitro. Although children recover from ES without any sequelae, neurological symptoms associated with exanthema subitum are often observed, and we could detect HHV 6 in the cerebrospinal fluid of ES patients. This result suggests that HHV 6 may invade the central nervous system and cause neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324560     DOI: 10.1111/j.1442-200x.1992.tb00969.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  4 in total

1.  Clinical characteristics of febrile convulsions during primary HHV-6 infection.

Authors:  S Suga; K Suzuki; M Ihira; T Yoshikawa; Y Kajita; T Ozaki; K Iida; Y Saito; Y Asano
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

2.  An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6.

Authors:  S LaCroix; J A Stewart; M E Thouless; J B Black
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

3.  Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection.

Authors:  Y Asano; T Yoshikawa; Y Kajita; R Ogura; S Suga; T Yazaki; T Nakashima; A Yamada; T Kurata
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

4.  Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

Authors:  P B Challoner; K T Smith; J D Parker; D L MacLeod; S N Coulter; T M Rose; E R Schultz; J L Bennett; R L Garber; M Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.